SynHelix (now Quantoom Biosciences, a Univercells Company)
Created in 2019
Up & running (A)
Existing signals show a regular activitySocial networks
676 9,190Activities
Technologies
Entity types
Location
4 Rue Pierre Fontaine, 91000 Évry-Courcouronnes, France
Évry-Courcouronnes
France
Employees
Scale: 11-50, 51-200
Estimated: 105
SIREN
848917373Engaged corporates
4
2 4Added in Motherbase
1 year, 8 months ago
biotech Value proposition
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
Molecular biology, synthetic biology, biotechnology, Biochemistry, Surface chemistry, lifesciences, computational biology, gene synthesis, gene therapy, cell therapy, bioeconomy, enzymology, Biocatalysis, Bioengineering, Enzyme engineering, Biotherapeutics, Protein engineering, Recombinant proteins, and nanotechnologyOriginal language
Large-scale DNA synthesis technology that harnesses natural enzymes.
Since January 2022, SynHelix is part of Quantoom Biosciences. Please go to the Quantoom Biosciences Linkedin page or www.quantoom.com for more information.
mRNA production reinvented • Quantoom Biosciences
By reinventing mRNA production, we remove barriers to manufacturing mRNA-based vaccines and therapeutics from R&D up to mass production
https://quantoom.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 hub.brussels Government Administration | hub.brussels Government Administration | Other 4 Mar 2025 | | |
 UCB Pharmaceutical Manufacturing | UCB Pharmaceutical Manufacturing | Other 28 Nov 2024 | | |
 EQUANS Environmental Services | EQUANS Environmental Services | Other 20 Jan 2025 | | |
 Noshaq Venture Capital and Private Equity Principals | Noshaq Venture Capital and Private Equity Principals | Other 28 Jul 2023 | | |